Wyeth to use Ambion's RNA:
This article was originally published in Clinica
Ambion RNA Diagnostics of Austin, Texas, is to develop and manufacture cGMP-grade RNA for pharmaceutical company Wyeth's vaccine programme. It will supply enough material for clinical trials. Ambion offers on a contract basis RNA synthesis, RNA isolation, diagnostic kits, controls and standards and RNA-based raw materials for bioprocessing.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.
Our updated graphic tracker of key developments from the leading vaccine candidates.